Our novel anti-EMT TF and anti-CSC antibodies are well-suited for IFA analysis of tumor tissue, and multiplex assays using several of these antibodies simultaneously will allow for careful dissection of the role of each target protein in preclinical specimens. This evidence concerns the gene TF and neoplasm.